TEALWOOD ASSET MANAGEMENT INC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1164062
Minneapolis, MN
Position in LGND
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,825,419
New position
Shares Held
5,775
first reported quarter
Ownership
0.029%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#158
of 411 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 74%
Shared 0%
None 26%
Position in Biotechnology
Healthcare · as of Jun 30, 2026TEALWOOD ASSET MANAGEMENT INC holds $17,219,176 across 10 Biotechnology names. LGND ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
7,561 | $2,810,196 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
36,233 | $1,990,641 | |
| 3 | ARGX |
Argenx SE
|
2,103 | $1,951,100 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
This page
|
5,775 | $1,825,419 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,492 | $1,734,581 | |
| 6 | EXEL |
Exelixis, Inc.
|
27,982 | $1,522,500 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
6,164 | $1,508,762 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,338 | $1,457,836 |
All Filings in LGND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,825,419 | 5,775 | Shares | Sole | 2026-07-14 | |
| No filing history on record for this holder in this stock. | ||||||